According to China Fund News, a number of pharmaceutical academic conferences have been postponed or cancelled recently, and a centralized notice has been issued to announce the postponement. Although the reasons for the postponement varied, most of the industry attributed it to the recent anti-corruption campaign in medicine. Judging from the details of the cases reported in the past, pharmaceutical companies have put on the "legal cloak" of bribery by holding academic conferences, such as conference sponsorship fees, expert lecture fees, and training fees.
As early as July 7, the discipline inspection and supervision organs cooperated with the mobilization and deployment of the national centralized rectification of corruption in the pharmaceutical field and held a video conference in Beijing, which emphasized that the pharmaceutical industry will be deeply carried out in all fields, the whole chain and the whole coverage of the system governance. We should pay close attention to leading cadres and personnel in key posts, persist in investigating bribery and bribery together, and concentrate efforts on investigating and handling a number of corruption cases in the pharmaceutical field.
In fact, people have suffered from medical corruption for a long time. Different from the past, this medical anti-corruption has a clear direction, a clear path, and prominent focus, such as focusing on the "key minority", identifying "new diseases", and investigating bribes together. As long as the key risk points are identified, a large part of the hidden corruption can be eradicated.
In terms of the "key minority", hospitals are getting bigger and bigger, and various management authorities are concentrated in the "number one", and if there is no effective supervision, it is easy to breed corruption. Since the beginning of this year, at least 155 hospital presidents and party secretaries have surrendered or been investigated.
Speaking of "new diseases", the medical industry has a long industrial chain and strong professionalism, which also poses a big challenge to supervision and discipline. Previously, some media reported that after the implementation of the "two-invoice system" and centralized procurement, some pharmaceutical companies turned to purchasing APIs at inflated prices, and collaborated with dealers to obtain funds for bribery.
Adhering to the principle of "accepting bribes and investigating them together" will help to control the source and fundamentally purify unhealthy tendencies in the field of medicine. In this regard, we must seriously rectify the situation and return the people to a pure land.
On the one hand, it is necessary to summarize the good practices in the anti-corruption of medicine in a timely manner, form a long-term mechanism, and make long-term efforts; On the other hand, in view of the "number one", it is necessary to strengthen supervision and promote the implementation of the job rotation system. In addition, it is advisable to explore the establishment of a "database of bad records of bribery and bribery in the medical and health system", and improve the system of prohibiting and punishing bribe-givers and bribe-takers.
Medical and health care is related to people's livelihood and well-being. We look forward to this round of anti-corruption actions, eradicating the chronic diseases accumulated over the years, and handing over an answer sheet that satisfies the public.
□ Dragon Zhu (media person)
(Beijing News)